Karen Akinsanya Ph.D.
Net Worth
Last updated:
What is Karen Akinsanya Ph.D. net worth?
The estimated net worth of Dr. Karen Akinsanya Ph.D. is at least $5,763,568 as of 15 Oct 2021. He owns shares worth $26,876 as insider, has earned $2,477,192 from insider trading and has received compensation worth at least $3,259,500 in Schrödinger, Inc..
What is the salary of Karen Akinsanya Ph.D.?
Dr. Karen Akinsanya Ph.D. salary is $651,900 per year as Executive Vice President, Chief Biomedical Scientist and Head of Discovery R&D in Schrödinger, Inc..
How old is Karen Akinsanya Ph.D.?
Dr. Karen Akinsanya Ph.D. is 57 years old, born in 1968.
What stocks does Karen Akinsanya Ph.D. currently own?
As insider, Dr. Karen Akinsanya Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Schrödinger, Inc. (SDGR) | Executive Vice President, Chief Biomedical Scientist and Head of Discovery R&D | 1,394 | $19.28 | $26,876 |
What does Schrödinger, Inc. do?
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Karen Akinsanya Ph.D. insider trading
Schrödinger, Inc.
Dr. Karen Akinsanya Ph.D. has made 12 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 1,393 units of SDGR stock worth $77,660 on 15 Oct 2021.
The largest trade he's ever made was exercising 37,738 units of SDGR stock on 16 Aug 2021. As of 15 Oct 2021 he still owns at least 1,394 units of SDGR stock.
Schrödinger key executives
Schrödinger, Inc. executives and other stock owners filed with the SEC:
- Dr. Karen Akinsanya Ph.D. (57) Executive Vice President, Chief Biomedical Scientist and Head of Discovery R&D
- Dr. Ramy Farid Ph.D. (61) Chief Executive Officer, Pres & Director
- Dr. Richard A. Friesner (72) Co-Founder, Scientific Advisory Chairman and Director
- Ms. Yvonne Tran Esq. (55) Executive Vice President, Chief Legal Officer & Sec.